BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35444805)

  • 1. Molecular Patho-mechanisms of cervical cancer (MMP1).
    Kurnia I; Rauf S; Hatta M; Arifuddin S; Hidayat YM; Natzir R; Kaelan C; Bukhari A; Pelupessy NU; Patelonggi IJ
    Ann Med Surg (Lond); 2022 May; 77():103415. PubMed ID: 35444805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
    Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
    Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of E6, p53, p16, MDM2 and Gal-3 in the clinical outcome of patients with cervical cancer.
    Stiasny A; Freier CP; Kuhn C; Schulze S; Mayr D; Alexiou C; Janko C; Wiest I; Dannecker C; Jeschke U; Kost BP
    Oncol Lett; 2017 Oct; 14(4):4467-4476. PubMed ID: 29085443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions.
    von Knebel Doeberitz M; Rittmüller C; Aengeneyndt F; Jansen-Dürr P; Spitkovsky D
    J Virol; 1994 May; 68(5):2811-21. PubMed ID: 8151752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    McFarlane M; MacDonald AI; Stevenson A; Graham SV
    J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E6/E7-P53-POU2F1-CTHRC1 axis promotes cervical cancer metastasis and activates Wnt/PCP pathway.
    Zhang R; Lu H; Lyu YY; Yang XM; Zhu LY; Yang GD; Jiang PC; Re Y; Song WW; Wang JH; Zhang CC; Gu F; Luo TJ; Wu ZY; Xu CJ
    Sci Rep; 2017 Mar; 7():44744. PubMed ID: 28303973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathology significance of p53 and p63 expression in Indonesian cervical squamous cell carcinomas.
    Romus I; Triningsih FE; Mangunsudirdjo S; Harijadi A
    Asian Pac J Cancer Prev; 2013; 14(12):7737-41. PubMed ID: 24460361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus 16 oncoprotein E7 stimulates UBF1-mediated rDNA gene transcription, inhibiting a p53-independent activity of p14ARF.
    Dichamp I; Séité P; Agius G; Barbarin A; Beby-Defaux A
    PLoS One; 2014; 9(5):e96136. PubMed ID: 24798431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papilloma virus early proteins E6 (HPV16/18-E6) and the cell cycle marker P16 (INK4a) are useful prognostic markers in uterine cervical carcinomas in Qassim Region--Saudi Arabia.
    Omran OM; AlSheeha M
    Pathol Oncol Res; 2015 Jan; 21(1):157-66. PubMed ID: 24925218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.
    Münger K; Scheffner M; Huibregtse JM; Howley PM
    Cancer Surv; 1992; 12():197-217. PubMed ID: 1322242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papilloma virus E7 oncoprotein abrogates the p53-p21-DREAM pathway.
    Fischer M; Uxa S; Stanko C; Magin TM; Engeland K
    Sci Rep; 2017 Jun; 7(1):2603. PubMed ID: 28572607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papilloma virus 16 E6 RNA interference enhances cisplatin and death receptor-mediated apoptosis in human cervical carcinoma cells.
    Tan S; Hougardy BM; Meersma GJ; Schaap B; de Vries EG; van der Zee AG; de Jong S
    Mol Pharmacol; 2012 May; 81(5):701-9. PubMed ID: 22328720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E6 and E7 Oncoproteins: Potential Targets of Cervical Cancer.
    Malla R; Kamal MA
    Curr Med Chem; 2021; 28(39):8163-8181. PubMed ID: 33176633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer.
    Chen TH; Huang CC; Yeh KT; Chang SH; Chang SW; Sung WW; Cheng YW; Lee H
    World J Gastroenterol; 2012 Aug; 18(30):4051-8. PubMed ID: 22912557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Panchvalkala, a traditional Ayurvedic formulation, exhibits antineoplastic and immunomodulatory activity in cervical cancer cells and C57BL/6 mouse papilloma model.
    Aphale S; Shinde K; Pandita S; Mahajan M; Raina P; Mishra JN; Kaul-Ghanekar R
    J Ethnopharmacol; 2021 Nov; 280():114405. PubMed ID: 34260879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism of carcinogenesis by human papillomavirus-16.
    Ishiji T
    J Dermatol; 2000 Feb; 27(2):73-86. PubMed ID: 10721654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
    Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
    Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells.
    Munagala R; Kausar H; Munjal C; Gupta RC
    Carcinogenesis; 2011 Nov; 32(11):1697-705. PubMed ID: 21859835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.